Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
38 studies found for:    "Cutaneous lupus erythematosus"
Show Display Options
Rank Status Study
1 Completed Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser
Condition: Cutaneous Lupus Erythematosus
Intervention: Procedure: laser treatment (Candela Vbeam Perfecta™)
2 Completed Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)
Condition: Cutaneous Lupus Erythematosus
Intervention: Drug: Tacrolimus ointment
3 Terminated A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Interventions: Drug: PD-0360324;   Drug: Placebo
4 Completed Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)
Condition: Cutaneous Lupus Erythematosus (CLE)
Intervention: Drug: lenalidomide (Revlimid®)
5 Completed To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention: Drug: CC-11050
6 Recruiting A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic;   Lupus Erythematosus, Discoid;   Healthy
Interventions: Procedure: Skin biopsy;   Procedure: Blood collection;   Procedure: Urine collection
7 Unknown  Cutaneous Lupus Erythematosus and Elidel
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Discoid
Intervention: Drug: Elidel (pimecrolimus)
8 Terminated Efficacy and Safety of Oral Alitretinoin (Toctino®) in the Treatment of Patients With Cutaneous Lupus Erythematosus
Condition: Lupus Erythematosus, Cutaneous
Intervention: Drug: Alitretinoin
9 Recruiting Prevalence and Clinical Severity of Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention:
10 Recruiting IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention: Drug: IVIg
11 Completed Sunscreens in Patients With Cutaneous Lupus Erythematosus(CLE)
Condition: Cutaneous Lupus Erythematosus
Intervention: Other: Daylong products
12 Completed A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic
Interventions: Drug: 1 mg/kg CNTO 136;   Drug: 4 mg/kg CNTO 136;   Drug: 10 mg/kg CNTO 136;   Drug: Placebo
13 Completed
Has Results
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention: Behavioral: Cutaneous Lupus educational script
14 Terminated Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus
Condition: Subacute Cutaneous Lupus Erythematosus
Interventions: Drug: KRP203 - 1.2mg;   Drug: Placebo to KRP203 - 1.2 mg
15 Completed Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion
Condition: Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Interventions: Drug: hydroxychloroquine (Z0188);   Drug: Placebo
16 Enrolling by invitation European Society of Cutaneous Lupus Erythematosus (EUSCLE)
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic
Intervention: Procedure: laboratory analysis
17 Completed Efficacy and Safety of Fumaric Acid Esters (Fumaderm®) in the Treatment of Patients With Cutaneous Lupus Erythematosus
Condition: Lupus Erythematosus, Cutaneous
Intervention: Drug: Fumaric acid esters
18 Completed A Non-drug Study Profiling Cutaneous Lupus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic;   Lupus Erythematosus, Discoid
Interventions: Procedure: No intervention, skin biopsy;   Procedure: No intervention, blood collection;   Procedure: No intervention, urine collection
19 Completed Sunscreen RV 2457C in Photoinduced CLE
Conditions: Cutaneous Lupus Erythematosus;   Skin Lesion;   Experimental Photoinduction;   Protective Sunscreen
Intervention: Drug: sunscreen RV 2547C
20 Terminated Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus
Condition: Cutaneous Lupus Erythematosus
Intervention: Dietary Supplement: vitamin D

   Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results    Last Page
Indicates status has not been verified in more than two years